Skip to main content

Table 1

From: Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)

Variable

BL (n = 15)

T3 (n = 15)

T6 (n = 11)

VL (copies/mL)

50 (50–251.967)

50 (50–296)

50 (50–50)

CD4 cell count (cells/mL)

170 (53–496)

206 (91–494)

213 (101–555)

CD4+ %

16.9% (7.8–27.3)

19.8 (7.2–27.1)

16.1 (6.5–21.1)

AST (UI/L)

35 (13–75)

39 (18–108)

34 (15–146)

ALT (UI/L)

53 (18–162)

52 (15–166)

59 (15–224)

TC (mg/dL)

164 (123–269)

180 (113–232)

166 (85–257)

TG (mg/dL)

176 (62–363)

171 (46–339)

192 (33–402)

Glycemia (mg/dL)

92 (74–212)

90 (77–198)

91 (76–208)